ReviewCardiovascular diabetology. Endocrinology reports2025

Effectiveness of SGLT2 inhibitors, incretin-based therapies, and finerenone on cardiorenal outcomes: a meta-analysis and network meta-analysis.

Arveen Shokravi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.